A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: A potential marker for early diagnosis

Parasitology International

Volumn 61, Issue 1, 2012, Pages 151-154

  Sawanyawisuth, Kanlayanee ^a   Silsirivanit, Atit ^a   Kunlabut, Kunlathida ^a   Tantapotinan, Nattawat ^a   Vaeteewoottacharn, Kulthida ^a   Wongkham, Sopit ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Bile duct; Carcinogenesis; Cholangiocarcinoma; Early marker; Liver fluke; Opisthorchis viverrini

Indexed keywords

CARBOHYDRATE ANTIGEN; CHOLANGIOCARCINOMA ASSOCIATED CARBOHYDRATE ANTIGEN; DIMETHYLNITROSAMINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY S121; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; EARLY DIAGNOSIS; EPITHELIUM; HAMSTER; LIVER; NONHUMAN; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, HELMINTH; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CRICETINAE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESOCRICETUS; MICE; MICE, TRANSGENIC; MUCIN 5AC; OPISTHORCHIASIS; OPISTHORCHIS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; CRICETINAE; FASCIOLA HEPATICA; MESOCRICETUS AURATUS; OPISTHORCHIS VIVERRINI;

EID: 82655172473     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2011.07.013     Document Type: Article

References (28)

1. Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., Thomas H.C. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002, 37:806-813.
2. Shaib Y., El-Serag H.B. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004, 24:115-125.
3. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001, 33:1353-1357.
4. Sripa B., Kaewkes S., Sithithaworn P., Mairiang E., Laha T., Smout M., et al. Liver fluke induces cholangiocarcinoma. PLoS Med 2007, 4:e201.
5. Thamavit W., Bhamarapravati N., Sahaphong S., Vajrasthira S., Angsubhakorn S. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 1978, 38:4634-4639.
6. Sirica A.E. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005, 41:5-15.
7. Gores G.J. Cholangiocarcinoma: current concepts and insights. Hepatology 2003, 37:961-969.
8. Silsirivanit A., Araki N., Wongkham C., Pairojkul C., Narimatsu Y., Kuwahara K., et al. A Novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Cancer 2011, 117:3393-3403.
9. Prakobwong S., Yongvanit P., Hiraku Y., Pairojkul C., Sithithaworn P., Pinlaor P., et al. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model. Int J Cancer 2010, 127:2576-2587.
10. Boonla C., Sripa B., Thuwajit P., Cha-On U., Puapairoj A., Miwa M., et al. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2005, 11:4939-4946.
11. Boonla C., Wongkham S., Sheehan J.K., Wongkham C., Bhudhisawasdi V., Tepsiri N., et al. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer 2003, 98:1438-1443.
12. Wongkham S., Sheehan J.K., Boonla C., Patrakitkomjorn S., Howard M., Kirkham S., et al. Serum MUC5AC mucin as a potential marker for cholangiocarcinoma. Cancer Lett 2003, 195:93-99.
13. Bamrungphon W., Prempracha N., Bunchu N., Rangdaeng S., Sandhu T., Srisukho S., et al. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Lett 2007, 247:301-308.
14. Paulsen F., Jager K., Worlitzsch D., Brauer L., Schulze U., Schafer G., et al. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann Anat 2008, 190:59-70.
15. Groux-Degroote S., Krzewinski-Recchi M.A., Cazet A., Vincent A., Lehoux S., Lafitte J.J., et al. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. Biochem J 2008, 410:213-223.
16. Andrianifahanana M., Moniaux N., Batra S.K. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 2006, 1765:189-222.
17. Hale W.B., Turner B., LaMont J.T. Oxygen radicals stimulate guinea pig gallbladder glycoprotein secretion in vitro. Am J Physiol 1987, 253:G627-G630.
18. Ninlawan K., O'Hara S.P., Splinter P.L., Yongvanit P., Kaewkes S., Surapaitoon A., et al. Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte. Parasitol Int 2010, 59:616-621.
19. Smout M.J., Laha T., Mulvenna J., Sripa B., Suttiprapa S., Jones A., et al. A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells. PLoS Pathog 2009, 5:e1000611.
20. Sripa B., Kaewkes S. Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis. Int J Parasitol 2000, 30:735-740.
21. Prakobwong S., Pinlaor S., Yongvanit P., Sithithaworn P., Pairojkul C., Hiraku Y. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int J Parasitol 2009, 39:825-835.
22. Boonmee S., Imtawil K., Wongkham C., Wongkham S. Comparative proteomic analysis of juvenile and adult liver fluke, Opisthorchis viverrini. Acta Trop 2003, 88:233-238.
23. Merlin J., Stechly L., de Beauce S., Monte D., Leteurtre E., van Seuningen I., et al. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Oncogene 2011, 30:2514-2525.
24. Wongkham S., Junking M., Wongkham C., Sripa B., Chur-In S., Araki N. Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma. Cancer Sci 2009, 100:2077-2084.
25. Mello M.L., Aldrovani M., Moraes A.S., Guaraldo A.M., Vidal Bde C. DNA content, chromatin supraorganization, nuclear glycoproteins and RNA amounts in hepatocytes of mice expressing insulin-dependent diabetes. Micron 2009, 40:577-585.
26. Chutiwitoonchai N., Shen Y., Zheng H., Xiong H., Zhao G., Imtawil K., et al. Opisthorchis viverrini: gene expression profiling of carcinogenic adult liver fluke worms using 5' SAGE. Exp Parasitol 2008, 120:306-313.
27. Suttiprapa S., Mulvenna J., Huong N.T., Pearson M.S., Brindley P.J., Laha T., et al. Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity. Int J Biochem Cell Biol 2009, 41:1148-1156.
28. Suttiprapa S., Loukas A., Laha T., Wongkham S., Kaewkes S., Gaze S., et al. Characterization of the antioxidant enzyme, thioredoxin peroxidase, from the carcinogenic human liver fluke, Opisthorchis viverrini. Mol Biochem Parasitol 2008, 160:116-122.